Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Mannino Raphael J, Directeur Scientifique. Officer active across 1 company, notably Matinas BioPharma Holdings, Inc.. Cumulatively, 2 disclosures have been recorded. History available since 19 June 2021. The latest transaction was disclosed on 3 September 2021 (J). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Raphael J. Mannino is the Chief Scientific Officer at Matinas BioPharma Holdings, Inc. He oversees the company's research and development initiatives, contributing to innovation in the pharmaceutical sector. His scientific expertise is crucial for the company's success.